Malin Corporation plc (MLC) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases.

Total Revenue Chart for Malin Corporation plc

Malin Corporation plc (MLC) revenue for FY2024 was EUR 0.00. Malin Corporation plc's revenue grew from EUR 22.9M in 2015 to EUR 0.00 in 2024 (-100.0% over 9 years). Earnings per share moved from EUR -1.51 in 2015 to EUR 0.82 in 2021.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (Euros)

R&D as % of Revenue

Key Stats

Market Cap
€30.28M
Implied Share Price
€7.00
Enterprise Value
-€31.82M
Revenue (TTM)
€41.00M
EBITDA
-€2.40M
Profit Margin
0.00%
Trailing P/E
0.00
Forward P/E
0.00
Price/Book (MRQ)
0.16
Price/Sales (TTM)
6.18
EV/EBITDA
186.08
EV/Revenue
6.08
Dividend Yield
—
Book Value
€8.90
Free Cash Flow (FY2024)
-€1.30M
Free Cash Flow Yield
-4.29%

Snapshot as of 15th August 2026 — not point-in-time controlled, may lag the live market by a few days.